Virtu Financial LLC Protalix Bio Therapeutics, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$1.22 - $1.82 $192,169 - $286,679	157,516 New	157,516 $198,000
Q3 2023 Nov 14, 2023	SELL	$1.49 - $2.02 $1,376 - $1,866	-924 Reduced 7.63%	11,184 $19,000
Q2 2023 Jul 27, 2023	BUY	$2.0 - $3.36 $24,216 - $40,682	12,108 New	12,108 $24,000
Q2 2022 Aug 09, 2022	BUY	$1.02 - $1.56 $13,889 - $21,242	13,617 Added 89.59%	28,816 $31,000
Q1 2022 May 17, 2022	SELL	$0.81 - $1.17 $2,569 - $3,711	-3,172 Reduced 17.27%	15,199 $16,000
Q4 2021 Feb 17, 2022	BUY	$0.81 - $1.33 $14,880 - $24,433	18,371 New	18,371 $15,000
Q2 2021 Sep 17, 2021	SELL	$1.86 - $6.22 $51,603 - $172,567	-27,744 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$3.58 - $6.45 $99,323 - $178,948	27,744 New	27,744 $124,000

5.61M

103K

4.6K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $52.2M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.